Medication Management and Pharmaceutical Care in Clinical Pharmacy

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: 30 June 2024 | Viewed by 1456

Special Issue Editor

Dr. Jennifer Schneider
E-Mail Website
Guest Editor
Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia
Interests: therapeutic drug monitoring and microsampling; drug stability; pharmacokinetics; palliative care
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Pharmacists have an important role to play in the quality use of medicines by advising on the selection of medicines and dosing, safe handling, storage and use, minimising harm from medications and monitoring outcomes. Knowledge of pharmacokinetics and pharmaceutics are unique skills that pharmacists bring to the health care team. Pharmacists may also be involved in clinical trials, laboratory-based studies developing new drugs, repurposing existing drugs or describing the pharmacokinetics of drugs, investigating the stability and compatibility of drug formulations and admixtures for clinical use or the use of technology to improve medication safety.

The aim of this Special Issue is to provide a platform for pharmacists to share their innovations, experiences, reviews and research and promote the discussion of topics relating to improving and informing medication use in different clinical settings.

Dr. Jennifer Schneider
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • quality use of medicines
  • pharmacokinetics
  • pharmaceutics
  • drug stability and compatibility
  • drug repurposing
  • clinical review of off-label use of medication
  • technology and medication
  • innovative approaches

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 472 KiB  
Article
COVID-19 Patients’ Medication Management during Transition of Care from Hospital to Virtual Care: A Cross-Sectional Survey and Audit
Pharmacy 2023, 11(5), 157; https://doi.org/10.3390/pharmacy11050157 - 28 Sep 2023
Cited by 1 | Viewed by 1183
Abstract
Background: Virtual models of care were implemented to ease hospital bed pressure during COVID-19. We evaluated the medication management of COVID-19 patients transferred to virtual models of care. Method: A retrospective audit of COVID-19 patients transferred from inpatient units to virtual care during [...] Read more.
Background: Virtual models of care were implemented to ease hospital bed pressure during COVID-19. We evaluated the medication management of COVID-19 patients transferred to virtual models of care. Method: A retrospective audit of COVID-19 patients transferred from inpatient units to virtual care during January 2022 and surveys from patients transferred during December 2021–February 2022 was carried out. Results: One hundred patients were randomly selected: mean age 59 years (SD: 19.8), mean number of medicines at admission 4.3 (SD: 4.03), mean length of virtual ward stay 4.4 days (SD: 2.1). Pharmacists reviewed 43% (43/100) of patients’ medications during their hospital stay and provided 29% (29/100) with discharge medicine lists at transfer. Ninety-two (92%) patients were prescribed at least one new high-risk medicine whilst in hospital, but this was not a factor considered to receive a pharmacist medication review. Forty patients (40%) were discharged on newly commenced high-risk medicines, and this was also not a factor in receiving a pharmacist discharge medication list. In total, 25% of patient surveys (96/378) were returned: 70% (66/96) reported adequate medicine information at transfer and 55% (52/96) during the virtual model period. Conclusion: Patient survey data show overall positive experiences of medication management and support. Audit data highlight gaps in medication management during the transfer to a virtual model, highlighting the need for patient prioritisation. Full article
(This article belongs to the Special Issue Medication Management and Pharmaceutical Care in Clinical Pharmacy)
Show Figures

Figure 1

Back to TopTop